Related Experiment Video
Updated: Jun 5, 2025

An In Vitro Caseum Binding Assay that Predicts Drug Penetration in Tuberculosis Lesions
Published on: May 8, 2017
Willingness for Active Case Finding of Tuberculosis among Community Pharmacists in Puducherry
Dhanajayan Govindan1, Palanivel Chinnakali2, Sonali Sarkar2
1Junior Resident, Department of Preventive and Social Medicine, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India.
Background:
In India, there is significant attrition in the cascade of care for tuberculosis (TB) in the public health sector. Pharmacy being the first point of contact for the majority holds considerable potential in reducing this attrition.
Objectives:
The objective of this study was to determine the willingness of pharmacists to screen and refer presumptive TB patients and understand challenges and enabling factors for the same.
Materials And Methods:
A sequential explanatory mixed-method study was conducted among pharmacies of Puducherry. Willingness to refer presumptive TB patients and collect sputum samples was summarized as proportions with 95% confidence interval. Log binomial regression was done to study the association of pharmacists' characteristics with willingness to refer. In-depth interviews with pharmacists were transcribed; manual content analysis with hybrid coding was done.
Results:
Among the 202 pharmacists interviewed, 99.0% were willing to refer, 37.1% were willing to collect sputum samples, and 42.6% had ever referred a patient in the past. Patients' lack of awareness, busy hours, and overuse of over-the-counter drugs hindered referral, while availability of quality diagnostic and treatment services, relationship with clients, and pharmacist's knowledge facilitated referral.
Conclusion:
Willingness to refer patients for TB diagnosis was high among pharmacists. The national program should consider the engagement of pharmacists for improving screening and referral.
More Related Videos
Related Concept Videos
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...

